Science & Medical

What is HHC, and Is it Legal in France?

HHC (hexahydrocannabinol) was first created in 1944 by American chemist Roger Adams when he added hydrogen molecules to delta-9-THC. However, since then, it has remained relatively obscure. That's starting to change now as legalization spreads throughout America and the rest of the world. Here we answer all the questions you might have about it, including those about its safety and effects.

Following the example of the United States, where the legalization of hemp has opened the way to the marketing of cannabinoids naturally present in hemp, but in very small quantities, and therefore recreated synthetically, some products containing HHC (hexahydrocannabinol) are starting to arrive in France. With a primary question: is HHC legal in France?

What is HHC?

HHC was created in 1944 by American chemist Roger Adams when he added hydrogen molecules to delta-9-THC. This process, called hydrogenation, converts THC into hexahydrocannabinol.

While Adams created HHC from THC derived from cannabis, today HHC is usually derived through a process that starts with hemp.

How is HHC made?

HHC can be made from a multi-step process. First, CBD is extracted from hemp in the form of an isolate. From there, things get a little more complicated.

HHC is created from CBD through a chemical reaction inside a chemical reactor using a catalyst. The details of this process are unknown, but toxic chemicals are likely involved.

The HHC contained in the marketed products is thus produced synthetically, without any traceability on the solvents involved and on what remains in the final product.

What are its effects on the body and mind?

There is no consensus on the potency of HHC. The complication comes, in part, from the fact that when the cannabinoid is made, the end result is a mixture of two different types of molecules: 9R HHC actively binds to the body’s natural endocannabinoid receptors, while 9S HHC, because of its slightly different molecular structure, doesn’t do so as well.

“The one that binds [to the receptors] produces similar effects” to delta-8 THC, but it takes a much larger amount to do so, explains Richard Sams of KCA Labs, for example. “With a sufficient dose, you can see effects similar to THC.”

In other words, HHC can have similar effects on the body and mind as THC, but HHC is less potent, milligram for milligram, than delta-8-THC. Delta-8-THC itself is generally considered half as potent as standard delta-9-THC.

Is it Safe for Consumption?

Like all new hemp-derived cannabinoids (delta-8, delta-10…), there is no standard dose and little or no research on the immediate or long-term effects of consumption.

Because hemp-derived cannabinoids (including HHC) are not properly regulated in France, sellers of HHC products are not required to test their products for potency and purity.

Is it Legal?

And now we come to perhaps the thorniest question of all: is HHC legal?

For the moment, hexahydrocannabinol is not classified on the list of narcotics in France nor is it prohibited as such. Attention all the same:

HHC is originally a derivative of THC. Its molecular structure is very close to the banned cannabinoid and its psychotropic effects, even if weak, could disqualify it quite easily

HHC has important similarities with the synthetic drugs K2 and Spice. No traceability is done on its production or its composition after manufacturing by solvent

For the moment, the products exist in a murky area. Until HHC is regulated by the state, consumers will only be able to assess the risks and benefits of these compounds for themselves.

__

Photo by Elsa Olofsson on Unsplash

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in NewsWeed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Desmond O'Flynn

Desmond O’Flynn believes in minimalism and the power of beer. As a young reporter for some of the largest national publications, he has lived in the world of finance and investing for nearly three decades. He has since included world politics and the global economy in his portfolio. He also writes about entrepreneurs and small businesses, as well as innovation in fintech, gambling, and cannabis industries.

Recent Posts

Women Represent 61% of Home Cannabis Growers in the U.S.

A survey found that women comprise 61% of home cannabis growers, marking a diversion from…

4 days ago

Denmark Proposes Making Its Medical Cannabis Program Permanent

Denmark plans to make its pilot medical cannabis program permanent following its success in treating…

5 days ago

Polish Lawmakers Petition Donald Tusk for Cannabis Decriminalization

Polish lawmakers have submitted a non-binding petition to Prime Minister Donald Tusk, urging cannabis decriminalization…

2 weeks ago

The UK Medical Cannabis Market: Growth, Diversification, and Opportunities

The UK medical cannabis market has rapidly grown since legalization in 2018, with private actors…

2 weeks ago

Alcohol & Cannabis: 60% of Cannabis Users Say It Helps Them Drink Less

A new study involving over 23,000 participants in New Zealand found that 60% of people…

2 weeks ago

French Interior and Justice Ministers Announce Measures to Combat Organized Crime

The French Ministers of the Interior and Justice announced a comprehensive plan to tackle organized…

2 weeks ago